IMMNOVImmunovia AB (publ)
0.1950SEK+3.17%Mkt Cap: 12.55M $P/E:

Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins a…

Industry Peers

Diagnostics & Research
Screen all
vs Diagnostics & Research
P/B
Avg
1M Perf
Higher
TMO
Thermo Fisher Scientific Inc.
$186.32BUSDP/E 27.6
DHR
Danaher Corporation
$134.82BUSDP/E 36.8
LONN
Lonza Group AG
$43.51BUSDP/E 42.0
IDXX
IDEXX Laboratories, Inc.
$41.53BUSDP/E 38.7
NTRA
Natera, Inc.
$38.88BUSD
A
Agilent Technologies, Inc.
$37.53BUSDP/E 26.7
WAT
Waters Corporation
$36.82BUSDP/E 47.7
IQV
IQVIA Holdings Inc.
$32.25BUSDP/E 24.0
ILMN
Illumina, Inc.
$26.60BUSDP/E 31.9
MTD
Mettler-Toledo International Inc.
$25.82BUSDP/E 30.0
DGX
Quest Diagnostics Incorporated
$23.46BUSDP/E 23.4
LH
Labcorp Holdings Inc.
$22.96BUSDP/E 24.8
GH
Guardant Health, Inc.
$19.89BUSD
MEDP
Medpace Holdings, Inc.
$15.12BUSDP/E 33.3
ERF
Eurofins Scientific SE
$12.91BUSDP/E 26.9
RVTY
Revvity, Inc.
$12.41BUSDP/E 53.5
CRL
Charles River Laboratories International, Inc.
$10.92BUSD
BIM
bioMérieux S.A.
$8.81BUSDP/E 20.6
TWST
Twist Bioscience Corporation
$6.41BUSD
BLLN
BillionToOne, Inc.
$5.52BUSDP/E 222.2
SHC
Sotera Health Company
$5.06BUSDP/E 43.3
RDNT
RadNet, Inc.
$4.85BUSD
VCYT
Veracyte, Inc.
$4.69BUSDP/E 54.4
DIA
DiaSorin S.p.A.
$3.65BUSDP/E 25.7
ADPT
Adaptive Biotechnologies Corporation
$3.43BUSD
GRAL
GRAIL, Inc.
$2.93BUSD
WGS
GeneDx Holdings Corp.
$2.04BUSD
NEO
NeoGenomics, Inc.
$1.90BUSD
VIMIAN
Vimian Group AB (publ)
$1.48BUSDP/E 37.4
DIA
Diagnostyka S.A.
$1.48BUSDP/E 22.4
CDNA
CareDx, Inc.
$1.47BUSD
PSNL
Personalis, Inc.
$1.40BUSD
OPK
OPKO Health, Inc.
$1.13BUSD
CBAV
Clínica Baviera, S.A.
$1.01BUSDP/E 21.1
CSTL
Castle Biosciences, Inc.
$723.37MUSD
LBIRD
Lumibird SA
$615.20MUSDP/E 40.1
FLGT
Fulgent Genetics, Inc.
$582.78MUSD
MYGN
Myriad Genetics, Inc.
$539.30MUSD
VOX
Voxel S.A.
$297.38MUSDP/E 3.0
EDT
Spectral Medical Inc.
$282.06MUSD
BDSX
Biodesix, Inc.
$233.52MUSD
IMDX
Insight Molecular Diagnostics Inc.
$190.51MUSD
SLV
Selvita S.A.
$147.80MUSD
XGN
Exagen Inc.
$112.34MUSD
ALECR
Eurofins-Cerep SA
$94.30MUSDP/E 18.2
BIOPOR
BioPorto A/S
$77.88MUSD
PANG
Pangaea Oncology, S.A.
$58.94MUSD
PRPO
Precipio, Inc.
$44.26MUSD
ABDX
Abingdon Health Plc
$27.97MUSD
NN6
NanoRepro AG
$27.15MUSD
GDR
genedrive plc
$22.69MUSD
SENZA
SenzaGen AB
$17.60MUSD
BMX
BioMaxima S.A.
$10.07MUSDP/E 63.2
ALPRE
Predilife S.A.
$9.85MUSD
VRCI
Verici Dx plc
$9.02MUSD
XWEL
XWELL, Inc.
$8.78MUSD
NDRA
ENDRA Life Sciences Inc.
$6.77MUSD
PRM
Proteome Sciences plc
$6.29MUSD
AVCR
Avricore Health Inc.
$5.98MUSD
BIAF
bioAffinity Technologies, Inc.
$5.10MUSD
OBD
Oxford BioDynamics Plc
$4.66MUSD
ISPC
iSpecimen Inc.
$3.81MUSD
JUMP
Leveljump Healthcare Corp.
$3.86MUSDP/E 2.8
TELO
Telo Genomics Corp.
$2.93MUSD
NOTV
Inotiv Inc
$2.79MUSD
PROGEN
Prostatype Genomics AB (publ)
$2.43MUSD
PRPH
ProPhase Labs, Inc.
$1.29MUSD
MBI-H
Many Bright Ideas Technologies Inc.
$314.2KUSDP/E Infinity
TTOO
T2 Biosystems, Inc.
$14.0KUSD
Indicators:|

Key Statistics

Company
Market Cap12.55M $
Enterprise Value6.84M $
Revenue (TTM)88.00K $
Gross Profit52.51K $
Net Income (TTM)-13.96M $
Revenue/Share0.0002 USD
Last Price0.1950 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees17
CountrySE
SectorHealthcare
IndustryDiagnostics & Research
ISINSE0006091997
Valuation
P/E (Trailing)
P/E (Forward)0.03
PEG
EV/EBITDA-0.89
EV/Revenue77.75
P/S135.12
P/B2.68
EPS (TTM)-0.26
EPS (Forward)7.00
52W Range
0.15027% of range0.7527
52W High0.7527 SEK
52W Low0.1502 SEK
Profitability
Gross Margin80.15%
Oper. Margin-4942.25%
EBITDA Margin0.00%
Profit Margin-21301.46%
ROE-225.30%
ROA-165.41%
Growth
Revenue Growth169.10%
Earnings Growth
Cash Flow & Leverage
Operating CF-7.50M $
CapEx (TTM)531.73K $
FCF Margin-4111.52%
FCF Yield-28.84%
Net Debt-5.32M $
Net Debt/EBITDA0.69
Balance Sheet
Debt/Equity0.01
Current Ratio3.05
Quick Ratio3.04
Book Value/Sh0.0690 SEK
Cash/Share0.0830 SEK
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 SEK
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:100
Split DateFeb 3, 2026
Analyst Consensus
Rating
Target (Mean)0.4200 SEK
Upside (mean)+115.4%
Target Range0.4200 SEK0.4200 SEK
# Analysts1
Ownership
Shares Out.672.67M
Float607.39M
Insiders10.70%
Institutions17.70%
Technical
SMA 500.1987 (-1.9%)
SMA 2000.2359 (-17.3%)
Beta2.68
S&P 52W Chg18.52%
Avg Vol (30d)3.80M
Avg Vol (10d)4.34M
Technical Indicators
RSI (14)49.8
MACD-0.0006
MACD Signal-0.0012
MACD Hist.+0.0006
BB Upper0.2105 SEK
BB Middle0.1932 SEK
BB Lower0.1760 SEK
BB Width17.87%
ATR (14)0.0152 SEK
Vol Ratio (20d)0.40x